220 related articles for article (PubMed ID: 34895643)
1. Escape from planarity in fragment-based drug discovery: A physicochemical and 3D property analysis of synthetic 3D fragment libraries.
Hamilton DJ; Dekker T; Klein HF; Janssen GV; Wijtmans M; O'Brien P; de Esch IJP
Drug Discov Today Technol; 2020 Dec; 38():77-90. PubMed ID: 34895643
[TBL] [Abstract][Full Text] [Related]
2. Escape from planarity in fragment-based drug discovery: A synthetic strategy analysis of synthetic 3D fragment libraries.
Klein HF; Hamilton DJ; de Esch IJP; Wijtmans M; O'Brien P
Drug Discov Today; 2022 Sep; 27(9):2484-2496. PubMed ID: 35636722
[TBL] [Abstract][Full Text] [Related]
3. Puckering the Planar Landscape of Fragments: Design and Synthesis of a 3D Cyclobutane Fragment Library.
Hamilton DJ; Beemsterboer M; Carter CM; Elsayed J; Huiberts REM; Klein HF; O'Brien P; de Esch IJP; Wijtmans M
ChemMedChem; 2022 May; 17(9):e202200113. PubMed ID: 35277937
[TBL] [Abstract][Full Text] [Related]
4. Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery.
Morrison CN; Prosser KE; Stokes RW; Cordes A; Metzler-Nolte N; Cohen SM
Chem Sci; 2019 Dec; 11(5):1216-1225. PubMed ID: 34123246
[TBL] [Abstract][Full Text] [Related]
5. Fragment-based screening with natural products for novel anti-parasitic disease drug discovery.
Liu M; Quinn RJ
Expert Opin Drug Discov; 2019 Dec; 14(12):1283-1295. PubMed ID: 31512943
[No Abstract] [Full Text] [Related]
6. Fragment-based drug discovery-the importance of high-quality molecule libraries.
Bon M; Bilsland A; Bower J; McAulay K
Mol Oncol; 2022 Nov; 16(21):3761-3777. PubMed ID: 35749608
[TBL] [Abstract][Full Text] [Related]
7. An Automated, Open-Source Workflow for the Generation of (3D) Fragment Libraries.
Dekker T; Janssen MACH; Sutherland C; Aben RWM; Scheeren HW; Blanco-Ania D; Rutjes FPJT; Wijtmans M; de Esch IJP
ACS Med Chem Lett; 2023 May; 14(5):583-590. PubMed ID: 37197454
[TBL] [Abstract][Full Text] [Related]
8. Design and Synthesis of 56 Shape-Diverse 3D Fragments.
Downes TD; Jones SP; Klein HF; Wheldon MC; Atobe M; Bond PS; Firth JD; Chan NS; Waddelove L; Hubbard RE; Blakemore DC; De Fusco C; Roughley SD; Vidler LR; Whatton MA; Woolford AJ; Wrigley GL; O'Brien P
Chemistry; 2020 Jul; 26(41):8969-8975. PubMed ID: 32315100
[TBL] [Abstract][Full Text] [Related]
9. From Protein Structure to Small-Molecules: Recent Advances and Applications to Fragment-Based Drug Discovery.
Ferreira LG; Andricopulo AD
Curr Top Med Chem; 2017; 17(20):2260-2270. PubMed ID: 28240184
[TBL] [Abstract][Full Text] [Related]
10. How Size Matters: Diversity for Fragment Library Design.
Shi Y; von Itzstein M
Molecules; 2019 Aug; 24(15):. PubMed ID: 31387220
[TBL] [Abstract][Full Text] [Related]
11. The 3F Library: Fluorinated Fsp
Troelsen NS; Shanina E; Gonzalez-Romero D; Danková D; Jensen ISA; Śniady KJ; Nami F; Zhang H; Rademacher C; Cuenda A; Gotfredsen CH; Clausen MH
Angew Chem Int Ed Engl; 2020 Feb; 59(6):2204-2210. PubMed ID: 31724281
[TBL] [Abstract][Full Text] [Related]
12. Using DNA-encoded libraries of fragments for hit discovery of challenging therapeutic targets.
Zhao G; Zhu M; Li Y; Zhang G; Li Y
Expert Opin Drug Discov; 2024 Jun; 19(6):725-740. PubMed ID: 38753553
[TBL] [Abstract][Full Text] [Related]
13. Two 'Golden Ratio' indices in fragment-based drug discovery.
Orita M; Ohno K; Niimi T
Drug Discov Today; 2009 Mar; 14(5-6):321-8. PubMed ID: 19028598
[TBL] [Abstract][Full Text] [Related]
14. On the origins of three-dimensionality in drug-like molecules.
Meyers J; Carter M; Mok NY; Brown N
Future Med Chem; 2016 Sep; 8(14):1753-67. PubMed ID: 27572621
[TBL] [Abstract][Full Text] [Related]
15. Fragment-to-Lead Medicinal Chemistry Publications in 2020.
de Esch IJP; Erlanson DA; Jahnke W; Johnson CN; Walsh L
J Med Chem; 2022 Jan; 65(1):84-99. PubMed ID: 34928151
[TBL] [Abstract][Full Text] [Related]
16. Recent Applications of Diversity-Oriented Synthesis Toward Novel, 3-Dimensional Fragment Collections.
Kidd SL; Osberger TJ; Mateu N; Sore HF; Spring DR
Front Chem; 2018; 6():460. PubMed ID: 30386766
[TBL] [Abstract][Full Text] [Related]
17. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.
Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A
J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493
[TBL] [Abstract][Full Text] [Related]
18. Fragment-based drug discovery using rational design.
Jhoti H
Ernst Schering Found Symp Proc; 2007; (3):169-85. PubMed ID: 18510103
[TBL] [Abstract][Full Text] [Related]
19. Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia.
Keserű GM; Erlanson DA; Ferenczy GG; Hann MM; Murray CW; Pickett SD
J Med Chem; 2016 Sep; 59(18):8189-206. PubMed ID: 27124799
[TBL] [Abstract][Full Text] [Related]
20. Hit triage using efficiency indices after screening of compound libraries in drug discovery.
Reitz AB; Smith GR; Tounge BA; Reynolds CH
Curr Top Med Chem; 2009; 9(18):1718-24. PubMed ID: 19929837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
